Makes you wonder what our CHF indication Rex-L is worth ?
https://www.bloomberg.com/news/arti...dmon-for-1-9-billion-expanding-drug-portfolio
Sanofi to Buy Kadmon for $1.9 Billion to Get Transplant Drug
Under Chief Executive Officer Paul Hudson, Sanofi has embarked on an acquisition spree to rejuvenate a pipeline that placed the French drugmaker behind rivals in terms of innovation and revenue potential. The agreement comes as health-care deals have been heating up. Last week, private equity firm Advent International and Singapore wealth fund GIC agreed to buy drugmaker Swedish Orphan Biovitrum AB for about $8 billion
Cell Therapy News/Articles, page-10902
-
- There are more pages in this discussion • 7,445 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |